search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
BODY CARE


Investigative methods dedicated to axilla skin


Fabrice Perin, Suparat Kasamtammakhun, Chanasak Pothi, Surachet Saelu, Kunyanatt Chalothorn - DermaProof Asia


The skin of the axilla (underarm or armpit area) has several distinctive characteristics that differentiate it from other body sites. These specificities are important to consider in the context of skin care, deodorants, antiperspirants, and overall hygiene. Compared to other parts of the body, some


of the key features of axillary skin are thinner epidermis and dermis (which makes it more sensitive and susceptible to irritation), its high density of sweat glands (eccrine, apocrine and apoeccrine, which are hybrid glands developing during puberty). The axilla is a hair-bearing area in both men and women where skin is often folded.


The combination of skin folds, nutrient-rich


sweat gland secretions and hairs creates a very favourable environment for bacterial growth leading to a distinct microbiome that includes a higher concentration of bacteria, especially Corynebacterium and Staphylococcus species. Organic molecules present in odourless


perspiration, especially apocrine perspiration, get metabolized by these bacteria. As an undesirable consequence, the axillary malodour is caused by a combination of volatile fatty acids, aldehydes, thioalcohols and steroids, which are byproducts from the bacterial metabolization of proteins and lipids present in human sweat. Removing axillary hairs, thus addressing the


issue of body odour, is important to improve self-esteem and decrease the negative effect upon social relationships.1


Yet the use of


shaving, waxing or other hair removal methods can contribute to irritation. The folded texture of the axilla region that


tends to retain more moisture and makes the skin prone to maceration, the use of deodorants and antiperspirants are factors further contributing to irritation, redness and itching. The same factors together with the friction inherent to this body area are responsible of the appearance of cutaneous hyperpigmentation. The last concern for many individuals is


the so-called ‘chicken skin’, a pictorial term describing the small, raised bumps that can appear on the skin of the armpits. The physiological specificities of the


axillary skin presented above implies the use of particular skin care, hygiene and aesthetic treatments. Removing axillary hair has become routine for women and men as well and helps mitigate armpit malodour.1 Antiperspirants and deodorants are used to reduce excessive sweating and mask odours.


www.personalcaremagazine.com


Products designed specifically for the sensitive axillary skin can also prevent or mitigate the risk of irritation or improve other conditions like hyperpigmentation and texture. In this short review article, we intend


to briefly present the rationale behind the rigorous evaluation of the cosmetic or aesthetic treatments for the axilla, focusing on in vivo test methods, which are the most suitable options in the perspective of gathering evidences to support claims. It is fair to assume that in vitro methods are primarily interesting for validating the proofs of concept of new active ingredients and interventions.


In vivo assessment of antiperspirants While mandatory efficacy testing is not universally required by law in all markets, it is often essential for regulatory approval, particularly in the USA and Canada where antiperspirants are regulated as over-the- counter drugs and drug products respectively, and can be crucial for making claims about


effectiveness in Europe and in many other countries. Furthermore, companies may voluntarily


conduct such testing to improve product credibility and align with industry standards. Although guidelines aiming at standardizing testing do not exist for many cosmetic claims, there are some for antiperspirants and deodorants.2


In the United States, the Food


and Drug Administration has an antiperspirant monograph that provides the regulatory framework for the safety and efficacy testing, and labeling claims. Demonstrating the effectiveness of an


antiperspirant means evaluating its ability to reduce sweating. The most common way to assess this effect is through gravimetric methods. The test consists in submitting the participants to controlled exercise or heat exposure to induce sweating. Pre-weighed filters or pads are used to


collect sweat from the underarms. The amount of sweat output is measured before and after


April 2025 PERSONAL CARE


59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132